Alliance A222001: A randomized, double-blind, placebo controlled phase II study of oxybutynin versus placebo for the treatment of hot flashes in men receiving androgen deprivation therapy. Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results